Underwriters are also getting better at detecting GLP-1 use through: Prescription databases Medical records requests Follow-up health questionnaires What This Means for Your Clients If currently on GLP-1 medications: Expect questions about medication use and duration Be prepared for potentially higher rates despite current health improvements Consider timing of application if they've been stable on medication for an extended period If recently stopped GLP-1 medications: Underwriters may view recent discontinuation as a risk factor Weight regain could further complicate the application process Medical follow-up showing sustained health improvements may help If planning to start GLP-1 medications: Understand that future applications may be affected by medication use Industry Trends to Watch Some forward-thinking insurance companies are exploring partnerships with GLP-1 providers to improve medication adherence

The key principle is that tirzepatide is more potent on a milligram basis than semaglutide, so direct milligram equivalents do not apply
How glutathione works is by inhibiting the tyrosinase enzyme that is important in melanin production and results in the improvement of the skin complexion
Trauma may be either a one-time trauma, which can be perceived as a single trauma, or there can be microtrauma at repeated intervals
G6PD deficiency tests : Diagnosis uses a quantitative G6PD enzyme assay as the gold standard, supported by complete blood count, reticulocyte count, peripheral smear (Heinz bodies, bite cells), and bilirubin and LDH levels
Widera E (2025)